Springhorn Jeremy P.

Avg. Two Year Performance

(29%) Avg. Purchase Return
(13%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return6%41%65%21%(29%)
Purchase Success Rate1 of 22 of 22 of 21 of 20 of 2
Average Sale Return(16%)(29%)(20%)(31%)0%
Sale Success Rate1 of 40 of 41 of 40 of 40 of 4

Syros Pharmaceuticals, Inc.

Other » Other

Chief Business Officer:

Holdings: 35.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Uniqure N.V.

Drugs » Biotechnology

Director:

Holdings: 19.57K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--